Female platelets have distinct functional activity compared with male platelets: Implications in transfusion practice and treatment of trauma-induced coagulopathy

• Published in: The journal of trauma and acute care surgery Vol. 87; no. 5; p. 1052
• Main Authors: Coleman, Julia R, Moore, Ernest E, Kelher, Marguerite R, Samuels, Jason M, Cohen, Mitchell J, Sauaia, Angela, Banerjee, Anirban, Silliman, Christopher C, Peltz, Erik D
• Format: Journal Article
• Language: English
• Published: United States 01.11.2019
• Subjects: Adenosine Diphosphate - metabolism; Adult; Aged; Blood Coagulation - physiology; Blood Coagulation Disorders - etiology; Blood Coagulation Disorders - physiopathology; Blood Platelets - metabolism; Estradiol - metabolism; Female; Healthy Volunteers; Humans; Male; Middle Aged; Platelet Activating Factor - metabolism; Platelet Activation - physiology; Platelet Aggregation - physiology; Platelet Function Tests; Postmenopause - blood; Premenopause - blood; Receptors, Fibrinogen - metabolism; Sex Factors; Wounds and Injuries - complications; Young Adult
• ISSN: 2163-0763
• DOI: 10.1097/TA.0000000000002398

Females are hypercoagulable and have survival benefit in trauma-induced coagulopathy (TIC). The mechanism for this sex-specific hypercoagulability is unknown. Platelets and platelet function are central in providing hemostatic potential and are the largest contributor to clot strength. Ligands (adenosine diphosphate [ADP] and platelet-activating factor [PAF]) bind distinct platelet receptors to potentiate activation and aggregation. We hypothesize that female platelets have a differential response to ADP and PAF, resulting in greater aggregation and activation compared to males, and that estradiol pretreatment of male or female platelets enhances this activity. Platelets were collected from healthy volunteers: premenopausal/postmenopausal females (≤54 years, >54 years) and similarly aged males. Platelet aggregometry and flow cytometry (fibrinogen binding capacity) were examined. After treatment with ADP or PAF, platelet aggregation was assessed with Chronolog and activation assessed by CD41 receptor surface expression using flow cytometry. Aggregation and activation were again assessed after platelet pretreatment with estradiol. Healthy volunteers included 12 premenopausal and 13 postmenopausal females and 18 similarly aged males. Female platelets (combined premenopausal and postmenopausal) had increased aggregation with ADP stimulation, as compared to male platelets. Male and female platelets had differential fibrinogen receptor expression, with female platelets (combined premenopausal and postmenopausal) demonstrating robust activation with ADP versus male platelets with PAF. In the presence of estradiol incubation, male platelets' activation with PAF approximated that of females (combined premenopausal and postmenopausal) and activation with PAF was enhanced in both male and female platelets. Male and female platelets have differential response to stimuli, suggesting sex-dependent signaling and cellular activation. Female platelets have both increased aggregation and activation potential, and estradiol pretreatment feminizes male platelets to approximate female platelet activation with PAF. These findings offer potential explanation for sex-based differences in hemostatic potential in TIC and question whether donor sex of transfused platelets should be considered in resuscitation. Estradiol may also serve as a novel therapeutic adjunct in TIC.